References
- Inzucchi SE , Bergenstal RM , Buse JB , Diamant M , Ferrannini E , Nauck M , et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–79
- Buse JB , Bergenstal RM , Glass LC , Heilmann CR , Lewis MS , Kwan AY , et al. Use of twice-daily exenatide in basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial. Ann Intern Med 2011;154:103–12
- Kachroo S , Kawabata H , Colilla S , Shi L , Zhao Y , Mukherjee J , Iloeje U , et al. Association between hypoglycemia and fall-related events in type 2 diabetes mellitus: analysis of a U.S. Commercial database. J Manag Care Spec Pharm 2015;21:243–53
- Kirkman SM , Briscoe VJ , Clark N , Florez H , Haas LB , Halter JB , Huang ES , et al. Consensus Development Conference on Diabetes and Older Adults. Diabetes in older adults: a consensus report. J Am Geriatr Soc 2012;60:2342–56
- Inzucchi SE , Bergenstal RM , Buse JB , Diamant M , Ferrannini E , Nauck M , Peters AL , et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015;38:140–9
- American Medical Directors Association . Clinical Practice Guidelines: Diabetes Management (© 2011, currently in revision). Available from http://www.amda.com/tools/guidelines.cfm#diabetes. Accessed March 19, 2015
- Garber AJ , Abrahamson MJ , Barzilay JI , Blonde L , Bloomgarden ZT , Bush MA , et al. AACE comprehensive diabetes management algorithm 2013. Endocr Pract 2013;19:327–36
- Balena R , Hensley IE , Miller S , Barnett AH . Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature. Diabetes Obes Metab 2013;15:485–502
- International Diabetes Foundation . Risk factors. Available from www.idf.org/about-diabetes/risk-factors. Accessed February 10, 2015
- Centers for Disease Control and Prevention . National Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014. Available from http://www.cdc.gov/diabetes/pubs/statsreport14/national-diabetes-report-web.pdf. Accessed March 13, 2015
- Zhang X , Decker FH , Luo H , Geiss LS , Pearson WS , Saaddine JB , et al. Trends in the prevalence and comorbidities of diabetes mellitus in nursing home residents in the United States: 1995-2004. J Am Geriatr Soc 2010;58:724–30
- Resnick HE , Heineman J , Stone R , Shorr RI . Diabetes in U.S. Nurs Homes, 2004. Diabetes Care 2008;31:287–8
- Travis SS , Buchanan RJ , Wang S , Kim M . Analyses of nursing home residents with diabetes at admission. J Am Med Dir Assoc 2004;5:320–7
- Pandya N , Wei W , Meyers JL , Kilpatrick BS , Davis KL . Burden of sliding scale insulin use in elderly long-term care residents with type 2 diabetes mellitus. J Am Geriatr Soc 2013;61:2103–10
- American Diabetes Association . Standards of medical care in diabetes–2015. Diabetes Care 2015;38:S5–S87
- Centers for Medicare & Medicaid Services . Nursing Home Quality Initiative. MDS 3.0 RAI Manual. 2013. Available from http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/NursingHomeQualityInits/MDS30RAIManual.html. Accessed February 10, 2015
- Lawton MP , Casten R , Parmelee PA , Van Haitsma K , Corn J , Kleban MH . Psychometric characteristics of the minimum data set II: validity. J Am Geriatr Soc 1998;46:736–44
- Mor V , Angelelli J , Jones R , Roy J , Moore T , Morris J . Inter-rater reliability of nursing home quality indicators in the U.S. BMC Health Serv Res 2003;3:20
- Mor V . A comprehensive clinical assessment tool to inform policy and practice: applications of the Minimum Data Set. Med Care 2004;42:III50–9
- Centers for Disease Control and Prevention . International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). 2011. Available from www.cdc.gov/nchs/icd/icd9cm.htm. Accessed February 10, 2015
- Cramer JA , Roy A , Burrell A , Fairchild CJ , Fuldeore MJ , Ollendorf DA , Wong PK . Medication compliance and persistence: terminology and definitions. Value Health 2008;11:44–7
- Mansbach WE , Mace RA , Clark KM . Differentiating levels of cognitive functioning: a comparison of the Brief Interview for Mental Status (BIMS) and the Brief Cognitive Assessment Tool (BCAT) in a nursing home sample. Aging Ment Health 2014;18:921–8
- Morris JN , Fries BE , Mehr DR , Hawes C , Phillips C , Mor V , Lipsitz LA . MDS Cognitive Performance Scale. J Gerontol 1994;49:M174–82
- Centers for Medicare & Medicaid Services . Nursing Home Data Compendium 2013 Edition. Available from https://www.cms.gov/Medicare/Provider-Enrollment-and-Certification/CertificationandComplianc/downloads/nursinghomedatacompendium_508.pdf. Accessed February 10, 2015
- American Diabetes Association . Executive summary: standards of medical care in Diabetes--2013. Diabetes Care 2013;36:S4–S10
- Zarowitz BJ , Conner C . The intersection of safety and adherence: new incretin-based therapies in patients with type 2 diabetes mellitus. Pharmacotherapy 2009;29:55S–67S
- Amori RE , Lau J , Pittas AG . Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis. JAMA 2007;298:194–206
- Dybicz SB , Thompson S , Molotsky S , Stuart B . Prevalence of diabetes and the burden of comorbid conditions among elderly nursing home residents. Am J Geriatr Pharmacother 2011;9:212–23
- Migdal A , Yarandi SS , Smiley D , Umpierrez GE . Update on diabetes in the elderly and in nursing home residents. J Am Med Dir Assoc 2011;12:627–32
- Zhang N , Li Y , Temkin-Greener H . Prevalence of obesity in New York nursing homes: associations with facility characteristics. Gerontologist 2013;53:567–81
- Lapane KL , Resnick L . Obesity in nursing homes: an escalating problem. J Am Geriatr Soc 2005;53:1386–91
- Cai S , Rahman M , Intrator O . Obesity and pressure ulcers among nursing home residents. Med Care 2013;51:478–86
- Heit JA . Venous thromboembolism epidemiology: implications for prevention and management. Semin Thromb Hemost 2002;28:3–13
- Falagas ME , Athanasoulia AP , Peppas G , Karageorgopoulos DE . Effect of body mass index on the outcome of infections: a systematic review. Obes Rev 2009;10:280–9
- Centers for Medicare & Medicaid Services . Quality Measures. Available from http://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/QualityMeasures/index.html?redirect=/QUALITYMEASURES/. [Accessed February 10, 2015]
- Levin PA , Wei W , Zhou S , Xie L , Baser O . Outcomes and treatment patterns of adding a third agent to 2 OADs in patients with type 2 diabetes. J Manag Care Pharm 2014;20:501–12
- Centers for Disease Control and Prevention . Diabetes Report Card 2012. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2012. Available from http://www.cdc.gov/diabetes/pubs/pdf/diabetesreportcard.pdf. Accessed February 10, 2015